Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003961 |
---|---|
Receipt number | R000004771 |
Scientific Title | XELOX(+bevacizumab), efficacy, safety, QOL Study:FOLFOX(+bevacizumab) after starting therapy, for patients can't continue continuous infusion therapy |
Date of disclosure of the study information | 2010/07/28 |
Last modified on | 2011/08/01 11:55:02 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/07/28 11:48:55 | ||
2 | Update | 2011/08/01 11:52:35 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
3 | Update | 2011/08/01 11:55:02 | Recruitment status |